ABPO (Abpro Holdings) Total Liabilities: $9.12 Mil (As of Mar. 2026)


ABPO Abpro Holdings Inc ABPO
9 GF Score
Price $0.22
! 1 Warning Sign
View Full Analysis

What is Abpro Holdings Total Liabilities?

Abpro Holdings ABPO +3.66% 9 Total Liabilities is $9.12 Mil as of Mar. 2026. GuruFocus rates ABPO with a GF Score™ of 9/100. The stock has 1 warning sign investors should review.

Abpro Holdings's Total Liabilities for the quarter that ended in Mar. 2026 was $9.12 Mil.

Abpro Holdings's quarterly Total Liabilities declined from Sep. 2025 ($17.30 Mil) to Dec. 2025 ($9.35 Mil) and declined from Dec. 2025 ($9.35 Mil) to Mar. 2026 ($9.12 Mil).

Abpro Holdings's annual Total Liabilities declined from Dec. 2023 ($91.79 Mil) to Dec. 2024 ($19.61 Mil) and declined from Dec. 2024 ($19.61 Mil) to Dec. 2025 ($9.35 Mil).

Abpro Holdings Total Liabilities Historical Data

* Premium members only.

The historical data trend for Abpro Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abpro Holdings Total Liabilities Chart

Abpro Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Liabilities
87.59 91.79 19.61 9.35

Abpro Holdings Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.61 20.43 17.30 9.35 9.12
ABPO
9GF Score
Abpro Holdings Inc ABPO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abpro Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Abpro Holdings's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.345+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=9.35

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1.063--8.282
=9.35

Abpro Holdings's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.117+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=9.12

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=6.865--2.252
=9.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $9.12 Mil mean?
Abpro Holdings (ABPO) has a Total Liabilities of $9.12 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Abpro Holdings and its competitors.
Is Abpro Holdings' Total Liabilities too high?
Abpro Holdings' current Total Liabilities is $9.12 Mil. Overall, Abpro Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Abpro Holdings' Total Liabilities compare to LYRA and ATXI?
Abpro Holdings' Total Liabilities of $9.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Abpro Holdings and its competitors. Abpro Holdings's current Total Liabilities is $9.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abpro Holdings stock overvalued right now?
Abpro Holdings (ABPO) has a current Total Liabilities of $9.12 Mil. The current Total Liabilities is $9.12 Mil. Abpro Holdings' overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Abpro Holdings (ABPO), the current Total Liabilities is $9.12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Abpro Holdings Business Description

Address 100 Summit Drive, Burlington, MA, USA, 01803
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. The company is focused on novel antibody constructs for immuno-oncology, ophthalmology, and infectious diseases. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, the company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
9GF Score

Get the complete analysis for ABPO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price